Advances in Immuno-oncology Congress
May 12, 2016 - May 13, 2016

London, United Kingdom | Kensington Close Hotel


Discovering new ways to effectively target and treat cancer is one of the most pressing challenges for the pharmaceutical industry today. The field of immuno-oncology is currently predicted to reach a value totalling $25 billion annually by 2020. At this crucial time of growth and advancement, this congress offers invaluable insights into key technological and scientific innovations. Addressing the main challenges and opportunities in the industry, delegates will learn more about hot areas including the discovery of novel viral, antibody and cell-based therapies, clinical partnerships and approaches to combination therapies.

Advances in Immuno-oncology Congress 2016

Evaluation of immune checkpoint markers and immune function of tumor infiltrated lymphocytes in tumor microenvironment
Dr. Emily Park, Senior Director in R&D at Advanced Cell Diagnostics
May 13th, 9:30am


Advances in Immuno-oncology Congress 2016

Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798



19 Barton Lane  
Abingdon Science Park
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420


Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051


For general information:
For place an order:
For product support:
For career opportunities: